— Know what they know.
Not Investment Advice
Also trades as: BLUEJET.NS (NSE) · $vol 5M

BLUEJET.BO BSE

Blue Jet Healthcare Limited
1W: -5.5% 1M: -7.9% 3M: -2.7% YTD: +22.5% 1Y: -31.5%
₹541.80 ($5.63)
+3.00 (+0.56%)
 
BSE · Healthcare · Biotechnology · Tech Score Sell · Power 33 · ₹93.7B mcap · 22M float · 0.179% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹93.7B ($972.7M)
52W Range325.2-693.15
Volume51,664
Avg Volume40,262
Beta0.62
Dividend₹1.20
Analyst Ratings
No analyst coverage
Company Info
CEOShiven Arora
Employees581
SectorHealthcare
IndustryBiotechnology
IPO Date2023-11-01
Bhumiraj Costarica, Plot No. 1 & 2
Thane, MA 400705
IN
91 22 2207 5307
About Blue Jet Healthcare Limited

Established in 1968 and based in Thane, India, Blue Jet Healthcare Limited is a key player in the pharmaceutical sector. The company primarily focuses on the manufacturing and sale of specialized chemical intermediates and active pharmaceutical ingredients (APIs), crucial components for a wide array of pharmaceutical and healthcare products. Its offerings encompass integrated intermediates for contrast media, saccharin and related salt compounds, alongside various niche pharmaceutical intermediates and APIs. Beyond product supply, Blue Jet also delivers comprehensive contract development and manufacturing (CDMO/CMO) solutions and associated development services. Demonstrating a broad global reach, the company conducts its business across India, Norway, the United States, Sweden, Italy, and Spain, among other international markets.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms